Recent News

Bank of America Tops Street Views On Q1 EPS, Revenue

Bank of America Tops Street Views On Q1 EPS, Revenue

Bank of America (BAC) shares were slightly higher pre-market Monday after the banking giant reported earnings and revenues above Street views. Bank of America reported Q1 EPS of $0.62, above the GAAP Street view of $0.60 as compiled by Capital IQ. A year ago the bank reported a like figure of $0.45. The bank reported Q1 revenue of $23.13 billion, […]

LSB Industries Launches $400 Mln Private Offering For Senior Secured Notes Due 2023

LSB Industries Launches $400 Mln Private Offering For Senior Secured Notes Due 2023

LSB Industries (LXU), a chemical manufacturer, has launched a private offering of $400 million in senior secured notes due 2023. Proceeds will be used to repurchase or redeem the company’s $375 million 8.5% notes due 2019. The tender offer for the notes is set to expire April 20. The company is offering $1,023.88 per $1,000 of notes. Remaining proceeds from […]

Boston Scientific Acquires Women’s Health Company nVision Medical

Boston Scientific Acquires Women’s Health Company nVision Medical

Boston Scientific (BSX), a medical technology company, said Thursday it has acquired nVision Medical Corporation, a women’s health company, for $150 million in upfront payment, and up to an additional $125 million in potential milestone payments. nVision has developed a device approved by the US Food and Drug Administration that collects cells from the fallopian tubes, offering a potential platform […]

Blueprint Medicines Reports Proof-of-Concept Data in RET-Altered Solid Tumors – Shares Up 6% Pre-Bell

Blueprint Medicines Reports Proof-of-Concept Data in RET-Altered Solid Tumors – Shares Up 6% Pre-Bell

Blueprint Medicines (BPMC) gained 6% pre-bell Monday after it reported proof-of-concept data from the ongoing phase 1 ARROW clinical trial of BLU-667 in patients with RET-altered solid tumors. BLU-667 is a selective inhibitor targeting oncogenic RET fusions and mutations, which are key drivers across multiple cancers, including subsets of patients with non-small cell lung cancer and medullary thyroid cancer. Among […]

Canada Manufacturing Shipment Values Rebound 1.9% in February

Canada Manufacturing Shipment Values Rebound 1.9% in February

Canada manufacturing shipment values rebounded 1.9% in February following a revised 1.3% drop in January (was -1.0%). The pick-up outpaced expectations (+1.0%), but Action Economics said it is not shocking given the anticipated resumption in vehicle sector sales. Indeed, Action Economics added, a 6.6% surge in transportation equipment sales drove the bounce in total manufacturing shipment values in February after […]

Bond Prices Aim Quietly Lower

US Treasury prices are little changed to slightly lower versus Thursday’s closes, having drifted slightly from Asian highs as equities gained more ground. Unwinding of tariff-driven fears helped the tone in global stocks, while investors looked toward strong earnings reports ahead. The threat of military action against Syria has kept trade cautious. The front end of the curve was hit […]